Published in Cancer Weekly, July 31st, 2007
"This study investigated the factors contributory to the heterogeneity of the ability of AFP to detect HCC. A total of 1,135 patients were categorized into four groups: HCC undergoing surgical resection (n=248), chronic hepatitis B (CHB, n=413), chronic hepatitis C...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.